New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 31, 2014
06:41 EDTGRFS, HOLXGrifols announces 7-year agreement with Japanese Red Cross
Grifols (GRFS) announced that it was selected by the Japanese Red Cross Society to be its partner in nucleic acid screening of the country's 5.3M annual blood donations. Under the terms of the 7-year agreement, Grifols will provide the JRC with its newest automation platform, the Procleix Panther System and associated assays, which the JRC will use to screen blood donations for HIV and Hepatitis viruses prior to their release for medical use. The Grifols Procleix brand products are developed as part of a partnership with Hologic (HOLX).
News For GRFS;HOLX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 30, 2015
07:51 EDTHOLXHologic turnaround intact as Tomo adoption accelerates, says UBS
UBS said the turn-around at Hologic is intact as adoption of its 3D Tomo instrument placements has accelerated. The firm said comps will get harder but with an overhaul of senior leadership, a pay down of debt, and an improved operational outlook, its buy thesis remains intact. UBS reiterated its Buy rating and $38 price target on Hologic shares.
April 29, 2015
16:12 EDTHOLXHologic sees Q3 EPS 38c-39c, consensus 39c
Subscribe for More Information
16:11 EDTHOLXHologic raises FY15 EPS view to $1.57-$1.59, consensus $1.57
Raises FY15 revenue view to $2.6B-$2.62B, consensus $2.6B.
16:09 EDTHOLXHologic reports Q2 EPS 41c, consensus 39c
Subscribe for More Information
15:00 EDTHOLXNotable companies reporting after market close
Subscribe for More Information
07:33 EDTHOLXHologic volatility elevated into Q2 and outlook
Subscribe for More Information
April 27, 2015
11:54 EDTHOLXHologic management to meet with Jefferies
Meeting to be held in New York on May 1 hosted by Jefferies.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use